27236097|t|The influence of liposomal formulation on the incorporation and retention of PNA oligomers
27236097|a|Liposomal formulations composed of phospholipids with different unsaturation degrees, head groups and at different cholesterol content have been tested for the encapsulation of Peptide Nucleic Acid (PNA) oligomers. The best loading capability (177μg, ER %=87.2) was obtained for pure liposomes of phosphatidylglycerol (DOPG) with negatively charged head group. The insertion of a 10-20% of cholesterol in DOPG based liposomes provides a slight decrease (∼160μg) of the PNA loading. On the other hand, the cholesterol addition (20-30%) slows down the PNA's release (∼27%) in fetal bovine serum from the liposomal formulation. Based on the encapsulation and the release properties, PEGylated DOPG liposomes with a percentage of cholesterol of 10-20% are the optimal formulation for the loading of PNA-a210.
27236097	17	26	liposomal	T103	UMLS:C0023828
27236097	77	90	PNA oligomers	T103	UMLS:C0600500
27236097	91	100	Liposomal	T103	UMLS:C0023828
27236097	126	139	phospholipids	T103	UMLS:C0031676
27236097	206	242	cholesterol content have been tested	T058	UMLS:C0201950
27236097	268	304	Peptide Nucleic Acid (PNA) oligomers	T103	UMLS:C0600500
27236097	375	384	liposomes	T103	UMLS:C0023828
27236097	388	408	phosphatidylglycerol	T103	UMLS:C0043840
27236097	410	414	DOPG	T103	UMLS:C0043840
27236097	421	439	negatively charged	T103	UMLS:C0003075
27236097	456	465	insertion	T058	UMLS:C0441587
27236097	481	492	cholesterol	T103	UMLS:C0008377
27236097	496	500	DOPG	T103	UMLS:C0043840
27236097	507	516	liposomes	T103	UMLS:C0023828
27236097	560	563	PNA	T103	UMLS:C0600500
27236097	596	607	cholesterol	T103	UMLS:C0008377
27236097	641	646	PNA's	T103	UMLS:C0600500
27236097	665	683	fetal bovine serum	T103	UMLS:C3812213
27236097	693	702	liposomal	T103	UMLS:C0023828
27236097	771	780	PEGylated	T103	UMLS:C0032483
27236097	781	785	DOPG	T103	UMLS:C0043840
27236097	786	795	liposomes	T103	UMLS:C0023828
27236097	817	828	cholesterol	T103	UMLS:C0008377
27236097	847	866	optimal formulation	T062	UMLS:C0524527
27236097	886	894	PNA-a210	T103	UMLS:C0600500